Drug Detection Device Based on NRL Technology Acknowledged as a Top Innovation of 2002


12/19/2002 - 61-02r
Contact: Public Affairs Office, (202) 767-2541


Patented NRL technology licensed to Lifepoint, Inc. through the Federal technology transfer program has been recognized by Popular Science magazine as one of the Top 100 Tech Innovations of 2002.

The Lifepoint device, called the Impact System, is a drug and alcohol testing method based on NRL's flow immunosensor. The flow immunosensor is a biosensor for small molecules developed by Drs. Fran Ligler, Anne Kusterbeck and Bruce Gaber of NRL's Center for Bio/Molecular Science and Engineering.

In 1992, NRL granted Lifepoint, Inc. (then U.S. Alcohol and Testing) an exclusive right to practice then patent-pending technology for detecting drugs of abuse. Later that same year, NRL signed a cooperative research and development agreement with the company to develop drug detection instruments based on the flow immunosensor.

The flow immunosensor uses the ability of antibodies to recognize specific molecules at high sensitivity. The antibodies are chemically attached to tiny beads contained within a cylinder the size of a pencil eraser. This chemical attachment immobilizes the antibodies, which bind fluorescently-labeled signal molecules that are structurally similar to the drug being tested. Test samples are then introduced into a water stream that flows through the cylinder. If the drug is present, it displaces the signal molecule, causing a fluorescent signal. The level of fluorescence is directly proportional to the amount of the drug contained in the sample.

Advantages of the flow immunosensor are its rapid response, portability for on-site testing, and low cost of operation. Additionally, the flow immunosensor is simple enough to be operated by semiskilled personnel.

Drs. Ligler and Kusterbeck received the 1992 Office of National Drug Control Policy Technology Transfer Award for Drug Enforcement in recognition of their significant technology transfer efforts supporting drug-control measures and specifically for their initiative in transferring the technology for the flow immunosensor.



Get NRL News: RSS


About the U.S. Naval Research Laboratory

The U.S. Naval Research Laboratory is the Navy's full-spectrum corporate laboratory, conducting a broadly based multidisciplinary program of scientific research and advanced technological development. The Laboratory, with a total complement of approximately 2,500 personnel, is located in southwest Washington, D.C., with other major sites at the Stennis Space Center, Miss., and Monterey, Calif. NRL has served the Navy and the nation for over 90 years and continues to meet the complex technological challenges of today's world. For more information, visit the NRL homepage or join the conversation on Twitter, Facebook, and YouTube.

Comment policy: We hope to receive submissions from all viewpoints, but we ask that all participants agree to the Department of Defense Social Media User Agreement. All comments are reviewed before being posted.